Licensing deals

graphic image of China flags overlapping with US flags

China's rapid rise creates 'heightened risks' for pharma: PwC

Analysts warned the evolution of Chinese biotech is creating “heightened risks related to IP security, regulatory compliance and strategic alignment.”

Nick Paul Taylor Jun 18, 2025 5:00am

Photo of a final puzzle piece about to fit into a puzzle

NextCure advances ADC pivot with $745M deal for phase 1 drug

Jun 16, 2025 9:52am

AstraZeneca pens $5.3B pact with CSPC to develop oral drugs

Jun 13, 2025 5:56am

Anatomical model of human arm and torso showing muscle

Eli Lilly inks $650M Juvena pact to find muscle-boosting drugs

Jun 11, 2025 7:30am

Novo Nordisk inks $812M Deep Apple deal to pursue obesity target

Jun 11, 2025 7:00am

Three blocks displaying from left to right a person a handshake and another person

BMS expands radiopharma pipeline

Jun 11, 2025 4:31am